Abstract
INT-0116 study established a new standard care for patients following curative resection of gastric cancer. However, the principal benefit associated with postoperative chemoradiation after radical operation (D2 lymphadenectomy) for advanced gastric cancer (stage III-IVM0) were less pronounced.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology, Biology, Physics
Paper Title
Journal
Date
